| Summary: | A spectral-domain OCT system operating at 1300 nm wavelength region, capable of acquiring 47,000 A-lines/s, was designed and developed. Its axial and transverse resolutions were ∼ 6 µm and ∼15 µm respectively. OCT images of human skin were obtained in vivo using three OCT systems, in order to find the optimal wavelength region for dermal imaging. 800 nm OCT system provided better image contrast over other two wavelength regions. Meanwhile, 1300 nm wavelength region was needed to obtain information from deeper dermal layers. To determine the effect of melanin pigmentation on OCT, images were taken from subjects with different ethnic origins. Interestingly, melanin pigmentation was found to have little effect on penetration depth in OCT. In vitro tumour samples, comprising samples with different degrees of dysplasia, were imaged at 800 nm, 1060 nm and 1300 nm wavelength regions to find the capability of OCT to diagnose microstructural changes occurring during tumour progression. 800 nm OCT system was capable to detect the malignant changes with higher contrast than other wavelength regions. However, higher wavelength regions were required to penetrate deeper in densely scattering tumour samples at advanced stages. OCT system operating at 1060 nm was combined with a photoacoustic imaging (PAT) system to obtain complementary information from biological tissues. This multimodal OCT/PAT system demonstrated its potential to deliver microstructural information based on optical scattering and vascular information based on optical absorption in living mice and human skin. The results indicate OCT as a promising imaging modality that can have profound applications in several areas of clinical diagnostic imaging.
|
|---|
